Squarepoint’s AMAG Pharmaceuticals AMAG Stock Holding History

Squarepoint’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-25,400	Closed	-$194K	–	3004
2020 Q2	$194K	Buy	+25,400	New	+$194K	﹤0.01%	1832
2020 Q1	–	Sell	-38,877	Closed	-$473K	–	2797
2019 Q4	$473K	Sell	38,877 -15,556	-29%	-$170K	﹤0.01%	1807
2019 Q3	$629K	Sell	54,433 -46,853	-46%	-$493K	0.01%	1501
2019 Q2	$1.01M	Sell	101,286 -5,750	-5%	-$62K	0.01%	1257
2019 Q1	$1.38M	Sell	107,036 -35,530	-25%	-$529K	0.01%	934
2018 Q4	$2.17M	Buy	142,566 +120,568	+548%	+$2.3M	0.03%	649
2018 Q3	$440K	Sell	21,998 -43,833	-67%	-$998K	0.01%	1360
2018 Q2	$1.28M	Sell	65,831 -33,918	-34%	-$750K	0.02%	797
2018 Q1	$2.01M	Buy	99,749 +75,215	+307%	+$1.27M	0.03%	571
2017 Q4	$325K	Sell	24,534 -111,599	-82%	-$1.68M	0.01%	1447
2017 Q3	$2.51M	Buy	+136,133	New	+$2.54M	0.05%	444
2017 Q1	–	Sell	-29,113	Closed	-$1.01M	–	2074
2016 Q4	$1.01M	Buy	+29,113	New	+$870K	0.04%	506
2016 Q2	–	Sell	-18,170	Closed	-$425K	–	1434
2016 Q1	$425K	Buy	18,170 +8,270	+84%	+$196K	0.03%	685
2015 Q4	$299K	Buy	+9,900	New	+$320K	0.03%	797
2015 Q3	–	Sell	-3,500	Closed	-$242K	–	630
2015 Q2	$242K	Buy	+3,500	New	+$220K	0.08%	334

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Squarepoint's AMAG Position: Q3 2020 in Review

Squarepoint sold out of AMAG Pharmaceuticals (AMAG) in Q3 2020, closing a stake of 25,400 shares — an estimated $194K sold.

Squarepoint first reported a position in AMAG in Q2 2015 and held it in 15 quarters. The position peaked at $2.51M in Q3 2017. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2020.

Squarepoint reported no remaining AMAG Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Squarepoint sold 25,400 AMAG Pharmaceuticals shares in Q3 2020, an estimated $194K.
Squarepoint first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 15 quarters.
Squarepoint's AMAG Pharmaceuticals position peaked at $2.51M in Q3 2017.
113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2020.

Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.